Dow Down0.22% Nasdaq Up0.14%

Ohr Pharmaceutical, Inc. (OHRP)

-NasdaqCM
8.16 Up 0.03(0.37%) 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2013Sep 30, 2012Sep 30, 2011
Total Revenue -   -   -  
Cost of Revenue -   -   -  
Gross Profit -   -   -  
Operating Expenses
Research Development2,610  1,626  522  
Selling General and Administrative2,011  1,661  721  
Non Recurring -   -   -  
Others -   -   -  
Total Operating Expenses -   -   -  
Operating Income or Loss (4,621) (3,286) (1,243)
Income from Continuing Operations
Total Other Income/Expenses Net(1,027)1,833  (3,856)
Earnings Before Interest And Taxes(5,648)(1,453)(5,099)
Interest Expense5  2  2  
Income Before Tax(5,652)(1,455)(5,102)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(5,652)(1,455)(5,102)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (5,652) (1,455) (5,102)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (5,652) (1,455) (5,102)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.